Mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical …

Since 2015, severe hydropericardium-hepatitis syndrome (HHS) associated with a novel
fowl adenovirus 4 (FAdV-4) has emerged in China, representing a new challenge for the …

Abstract The SARS-CoV-2 receptor, ACE2, is found on pericytes, contractile cells
enwrapping capillaries that regulate brain, heart and kidney blood flow. ACE2 converts …

The SARS-CoV-2 receptor binding domain (RBD) is both the principal target of neutralizing
antibodies and one of the most rapidly evolving domains, which can result in the emergence …

We assessed a cohort of people living with human immunodeficiency virus (PLWH)(n= 110)
and HIV negative controls (n= 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all …

The outbreak of the current coronavirus disease (COVID‐19) occurred in late 2019 and
quickly spread all over the world. The severe acute respiratory syndrome coronavirus‐2 …

Omicron has become the globally dominant severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) variant, creating additional challenges due to its ability to evade …

Memory B cells (MBCs) generate rapid antibody responses upon secondary encounter with
a pathogen. Here, we investigated the kinetics, avidity, and cross-reactivity of serum …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in millions of deaths worldwide and …

Abstract Coronavirus disease 2019 (COVID‐19) manifests with high clinical variability and
warrants sensitive and specific assays to analyze immune responses in infected and …